The Endoscope-Radiofrequency Ablation (RFA) Market is expected to register a CAGR of 8.7% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Application (Cardiology Applications, Pain Management, Oncology Applications, Other Applications). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Endoscope-Radiofrequency Ablation (RFA) Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Endoscope-Radiofrequency Ablation (RFA) Market Segmentation
Application- Cardiology Applications
- Pain Management
- Oncology Applications
- Other Applications
Strategic Insights
Endoscope-Radiofrequency Ablation (RFA) Market Growth Drivers- Increase in the Prevalence of Gastrointestinal Diseases: This market is mainly driven by the fast-rising incidence of gastrointestinal diseases such as gastroesophageal reflux disease and Barrett's esophagus. Radiofrequency ablation has become a rising popular preference because it is minimally invasive, with fewer side effects, which is what healthcare providers are looking for in solutions that improve patient outcomes and drive the market.
- Advancements in Endoscopic Technology: Improving safety and efficiency of procedures through advances in endoscopic instruments and radiofrequency technology. Emerging imaging modalities and precision delivery systems available in ablation are making treatments more clinically attractive to clinicians and palatable to patients, which enhances adoption, thereby propelling further growth in this industry.
- Increasing Awareness and Education: Increased awareness and education about endoscopic radiofrequency ablation benefits are the leading factors propelling this market forward. Well-informed patients are increasingly demanding minimally invasive interventions if these are explained in detail to them regarding treatment and management options for gastrointestinal diseases. Other patient education initiatives initiated by healthcare providers further facilitate more acceptance and usage.
- Introdction of Hybrid Techniques Development: Hybrid techniques with the integration of endoscopic radiofrequency ablation along with other minimally invasive techniques are being accepted more rapidly. Hybrid techniques enable the treatment of more complex diseases, such as obesity and Barrett's esophagus, by maximizing the advantages of various technologies. This trend stimulates innovation and extends the scope of therapeutic alternatives.
- Gastroenterology to Other Streams of Application: Endoscope radiofrequency ablation is now used for a lot more than just traditional gastroenterological uses. The practice is now finding its way to wider applications such as pulmonology and urology due to successful clinical outcomes in diseases such as lung tumors and urinary tract disorders. Hence, it offers wider possibilities for expansion in the market.
- Patient-Centric Solutions: The market for endoscope-radiofrequency ablation is getting very patient-centric with respect to solutions wherein patient centrality is gaining momentum, and the size of the market continues to grow further. For example, the development of simpler devices and programs according to each patient's needs can be considered as an overall aspect of such patient-centric solutions. A higher focus on patient experience and satisfaction is driving innovation into better adherence and clinical outcomes.
- Innovations in Ablation Devices: New innovations with ablation devices are opening up new growth in the market. Advances in endoscopic instruments can critically influence procedure success. Companies that focus their R&D on next-generation devices will be better positioned to take advantage of these shifting imperatives from providers and patients.
- Growth in Collaborations and Partnerships: Other emerging opportunities in the endoscope-radiofrequency ablation market are strategic partnerships between medical device companies and healthcare providers. This is a route that can ensure that all the expertise, technology, and resources from both parties are leveraged to improve the development of products and enhance training programs, driving wider adoption of ablation techniques across specialties.
- Growing Demand for Training and Education: Expansion in demand for education and training in endoscopic techniques is an opportunity in the market. The need to enhance skills in radiofrequency ablation creates increased demand from healthcare professionals through educational training programs and workshops, indirectly driving companies to develop educational resources and help boost market growth.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Endoscope-Radiofrequency Ablation (RFA) Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Endoscope-Radiofrequency Ablation (RFA) Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?

Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Frequently Asked Questions
Arthrex Inc., AtriCure Inc., and Boston Scientific Corporation are some of the major players operating in the market.
The oncology applications segment accounts for the highest revenue in application segment of the market in 2023.
Asia Pacific region accounted for the highest CAGR in the endoscope-radiofrequency ablation (RFA) market.
The Endoscope-Radiofrequency Ablation (RFA) Market is estimated to witness a CAGR of 8.7% from 2023 to 2031
North America region dominated the endoscope-radiofrequency ablation (RFA) market in 2023.
The major factors driving the endoscope-radiofrequency ablation (RFA) market are:
1. Increase in the Prevalence of Gastrointestinal Diseases.
2. Advancements in Endoscopic Technology.
3. Increasing Awareness and Education.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Endoscope-Radiofrequency Ablation (RFA) Market - By Application
1.3.2 Endoscope-Radiofrequency Ablation (RFA) Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) MARKET - GLOBAL MARKET ANALYSIS
6.1. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) - GLOBAL MARKET OVERVIEW
6.2. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CARDIOLOGY APPLICATIONS
7.3.1. Overview
7.3.2. Cardiology Applications Market Forecast and Analysis
7.4. PAIN MANAGEMENT
7.4.1. Overview
7.4.2. Pain Management Market Forecast and Analysis
7.5. ONCOLOGY APPLICATIONS
7.5.1. Overview
7.5.2. Oncology Applications Market Forecast and Analysis
7.6. OTHER APPLICATIONS
7.6.1. Overview
7.6.2. Other Applications Market Forecast and Analysis
8. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Endoscope-Radiofrequency Ablation (RFA) Market Overview
8.1.2 North America Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis
8.1.3 North America Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Application
8.1.4 North America Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Countries
8.1.4.1 United States Endoscope-Radiofrequency Ablation (RFA) Market
8.1.4.1.1 United States Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.1.4.2 Canada Endoscope-Radiofrequency Ablation (RFA) Market
8.1.4.2.1 Canada Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.1.4.3 Mexico Endoscope-Radiofrequency Ablation (RFA) Market
8.1.4.3.1 Mexico Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.2. EUROPE
8.2.1 Europe Endoscope-Radiofrequency Ablation (RFA) Market Overview
8.2.2 Europe Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis
8.2.3 Europe Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Application
8.2.4 Europe Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Endoscope-Radiofrequency Ablation (RFA) Market
8.2.4.1.1 Germany Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.2.4.2 France Endoscope-Radiofrequency Ablation (RFA) Market
8.2.4.2.1 France Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.2.4.3 Italy Endoscope-Radiofrequency Ablation (RFA) Market
8.2.4.3.1 Italy Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.2.4.4 Spain Endoscope-Radiofrequency Ablation (RFA) Market
8.2.4.4.1 Spain Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.2.4.5 United Kingdom Endoscope-Radiofrequency Ablation (RFA) Market
8.2.4.5.1 United Kingdom Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Endoscope-Radiofrequency Ablation (RFA) Market Overview
8.3.2 Asia-Pacific Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis
8.3.3 Asia-Pacific Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Application
8.3.4 Asia-Pacific Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Endoscope-Radiofrequency Ablation (RFA) Market
8.3.4.1.1 Australia Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.3.4.2 China Endoscope-Radiofrequency Ablation (RFA) Market
8.3.4.2.1 China Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.3.4.3 India Endoscope-Radiofrequency Ablation (RFA) Market
8.3.4.3.1 India Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.3.4.4 Japan Endoscope-Radiofrequency Ablation (RFA) Market
8.3.4.4.1 Japan Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.3.4.5 South Korea Endoscope-Radiofrequency Ablation (RFA) Market
8.3.4.5.1 South Korea Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Endoscope-Radiofrequency Ablation (RFA) Market Overview
8.4.2 Middle East and Africa Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis
8.4.3 Middle East and Africa Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Application
8.4.4 Middle East and Africa Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Endoscope-Radiofrequency Ablation (RFA) Market
8.4.4.1.1 South Africa Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.4.4.2 Saudi Arabia Endoscope-Radiofrequency Ablation (RFA) Market
8.4.4.2.1 Saudi Arabia Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.4.4.3 U.A.E Endoscope-Radiofrequency Ablation (RFA) Market
8.4.4.3.1 U.A.E Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Endoscope-Radiofrequency Ablation (RFA) Market Overview
8.5.2 South and Central America Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis
8.5.3 South and Central America Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Application
8.5.4 South and Central America Endoscope-Radiofrequency Ablation (RFA) Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Endoscope-Radiofrequency Ablation (RFA) Market
8.5.4.1.1 Brazil Endoscope-Radiofrequency Ablation (RFA) Market by Application
8.5.4.2 Argentina Endoscope-Radiofrequency Ablation (RFA) Market
8.5.4.2.1 Argentina Endoscope-Radiofrequency Ablation (RFA) Market by Application
9. INDUSTRY LANDSCAPE
9.1. MERGERS AND ACQUISITIONS
9.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
9.3. NEW PRODUCT LAUNCHES
9.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
10. ENDOSCOPE-RADIOFREQUENCY ABLATION (RFA) MARKET, KEY COMPANY PROFILES
10.1. ANGIODYNAMICS, INC.
10.1.1. Key Facts
10.1.2. Business Description
10.1.3. Products and Services
10.1.4. Financial Overview
10.1.5. SWOT Analysis
10.1.6. Key Developments
10.2. ARTHREX, INC.
10.2.1. Key Facts
10.2.2. Business Description
10.2.3. Products and Services
10.2.4. Financial Overview
10.2.5. SWOT Analysis
10.2.6. Key Developments
10.3. ATRICURE, INC.
10.3.1. Key Facts
10.3.2. Business Description
10.3.3. Products and Services
10.3.4. Financial Overview
10.3.5. SWOT Analysis
10.3.6. Key Developments
10.4. BOSTON SCIENTIFIC CORPORATION
10.4.1. Key Facts
10.4.2. Business Description
10.4.3. Products and Services
10.4.4. Financial Overview
10.4.5. SWOT Analysis
10.4.6. Key Developments
10.5. CONMED CORPORATION
10.5.1. Key Facts
10.5.2. Business Description
10.5.3. Products and Services
10.5.4. Financial Overview
10.5.5. SWOT Analysis
10.5.6. Key Developments
10.6. HALYARD HEALTH, INC.
10.6.1. Key Facts
10.6.2. Business Description
10.6.3. Products and Services
10.6.4. Financial Overview
10.6.5. SWOT Analysis
10.6.6. Key Developments
10.7. HOLOGIC, INC.
10.7.1. Key Facts
10.7.2. Business Description
10.7.3. Products and Services
10.7.4. Financial Overview
10.7.5. SWOT Analysis
10.7.6. Key Developments
10.8. MEDTRONIC PLC.
10.8.1. Key Facts
10.8.2. Business Description
10.8.3. Products and Services
10.8.4. Financial Overview
10.8.5. SWOT Analysis
10.8.6. Key Developments
10.9. SMITH AND NEPHEW PLC.
10.9.1. Key Facts
10.9.2. Business Description
10.9.3. Products and Services
10.9.4. Financial Overview
10.9.5. SWOT Analysis
10.9.6. Key Developments
10.10. STRYKER CORPORATION
10.10.1. Key Facts
10.10.2. Business Description
10.10.3. Products and Services
10.10.4. Financial Overview
10.10.5. SWOT Analysis
10.10.6. Key Developments
11. APPENDIX
11.1. ABOUT THE INSIGHT PARTNERS
11.2. GLOSSARY OF TERMS
1. AngioDynamics, Inc.
2. Arthrex, Inc.
3. AtriCure, Inc.
4. Boston Scientific Corporation
5. Conmed Corporation
6. Halyard Health, Inc.
7. Hologic, Inc.
8. Medtronic Plc.
9. Smith & Nephew Plc.
10. Stryker Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.